相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Rosiglitazone promotes tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis by reactive oxygen species-mediated up-regulation of death receptor 5 and down-regulation of c-FLIP
Yeoun Hee Kim et al.
FREE RADICAL BIOLOGY AND MEDICINE (2008)
Decisive role of cyclooxygenase-2 and lipocalin-type prostaglandin D synthase in chemotherapeutics-induced apoptosis of human cervical carcinoma cells
K. Eichele et al.
ONCOGENE (2008)
Growth inhibition and apoptosis induced in human leiomyoma cells by treatment with the PPAR gamma ligand ciglitizone
Dong-Ho Nam et al.
MOLECULAR HUMAN REPRODUCTION (2007)
β-Carotene induces apoptosis and up-regulates peroxisome proliferator-activated receptor γ expression and reactive oxygen species production in MCF-7 cancer cells
Yanhong Cui et al.
EUROPEAN JOURNAL OF CANCER (2007)
A novel natural compound, a cycloanthranilylproline derivative (Fuligocandin B), sensitizes leukemia cells to apoptosis induced by tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) through 15-deoxy-Δ12,14 prostaglandin J2 production
Hiroo Hasegawa et al.
BLOOD (2007)
Transcription coactivators for peroxisome proliferator-activated receptors
Songtao Yu et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS (2007)
Present concepts and outlook: Function of proliferator-activated receptors (PPARs) for future peroxisome pathogenesis, progression, and therapy of cancer
P. Sertznig et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2007)
Rosiglitazone sensitizes MDA-MB-231 breast cancer cells to anti-tumour effects of tumour necrosis factor-α, CH11 and CYC202
Manali Mody et al.
ENDOCRINE-RELATED CANCER (2007)
Peroxisome proliferator-activated receptor-γ antagonists exhibit potent antiproliferative effects versus many hematopoietic and epithelial cancer cell lines
Jack D. Burton et al.
ANTI-CANCER DRUGS (2007)
Synergy between PPARγ ligands and platinum-based drugs in cancer
Geoffrey D. Girnun et al.
CANCER CELL (2007)
Role of Bcl-2 family members in anoxia induced cell death
Emelyn H. Shroff et al.
CELL CYCLE (2007)
PPARγ inhibitors reduce tubulin protein levels by a PPARγ, PPARδ and proteasome-independent mechanism, resulting in cell cycle arrest, apoptosis and reduced metastasis of colorectal carcinoma cells
Katherine L. Schaefer et al.
INTERNATIONAL JOURNAL OF CANCER (2007)
PPAR gamma ligands enhance TRAIL-induced apoptosis through DR5 upregulation and c-FLIP downregulation in human lung cancer cells
Wei Zou et al.
CANCER BIOLOGY & THERAPY (2007)
15-Deoxy-Delta(12),(14)-prostaglandin J(2) enhances docetaxel anti-tumor activity against A549 and H460 non-small-cell lung cancer cell lines and xenograft tumors
Suniket V. Fulzele et al.
ANTI-CANCER DRUGS (2007)
Peroxisome proliferator-activated receptor gamma: a novel target for cancer therapeutics?
ShouWei Han et al.
ANTI-CANCER DRUGS (2007)
Peroxisome proliferator-activated receptor-γ activates p53 gene promoter binding to the nuclear factor-κB sequence in human MCF7 breast cancer cells
Daniela Bonofiglio et al.
MOLECULAR ENDOCRINOLOGY (2006)
Gonadotropin-induced apoptosis in human ovarian surface epithelial cells is associated with cyclooxygenase-2 up-regulation via the β-catenin/T-cell factor signaling pathway
Yuen Lam Pon et al.
MOLECULAR ENDOCRINOLOGY (2006)
Apoptosis induced by troglitazone is both peroxisome proliferator-activated receptor-γ- and ERK-dependent in human non-small lung cancer cells
Mingyue Li et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2006)
Dual PPAR α/γ ligand TZD18 either alone or in combination with imatinib inhibits proliferation and induces apoptosis of human CML cell lines
Chuanbing Zang et al.
CELL CYCLE (2006)
PPARγ is a key target of butyrate-induced caspase-3 activation in the colorectal cancer cell line Caco-2
Markus Schwab et al.
APOPTOSIS (2006)
15-Deoxy-Δ 12,14-prostaglandin J2 induces death receptor 5 expression through mRNA stabilization independently of PPARγ and potentiates TRAIL-induced apoptosis
Susumu Nakata et al.
MOLECULAR CANCER THERAPEUTICS (2006)
PPARγ insufficiency promotes follicular thyroid carcinogenesis via activation of the nuclear factor-κB signaling pathway
Y Kato et al.
ONCOGENE (2006)
A novel peroxisome proliferator-activated receptor γ ligand, MCC-555, induces apoptosis via posttranscriptional regulation of NAG-1 in colorectal cancer cells
Kiyoshi Yamaguchi et al.
MOLECULAR CANCER THERAPEUTICS (2006)
Growth inhibition and apoptosis in human Philadelphia chromosome-positive lymphoblastic leukemia cell lines by treatment with the dual PPARα/γ ligand TZD 18
HY Liu et al.
BLOOD (2006)
Novel high-affinity PPARγ agonist alone and in combination with paclitaxel inhibits human anaplastic thyroid carcinoma tumor growth via p21WAF1/CIP1
JA Copland et al.
ONCOGENE (2006)
Delineation, functional validation, and bioinformatic evaluation of gene expression in thyroid follicular carcinomas with the PAX8-PPARG translocation
TJ Giordano et al.
CLINICAL CANCER RESEARCH (2006)
A peroxisome proliferator-activated receptor-γ agonist, troglitazone, facilitates caspase-8 and-9 activities by increasing the enzymatic activity of protein-tyrosine phosphatase-1B on human glioma cells
Y Akasaki et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
PPARγ-independent induction of growth arrest and apoptosis in prostate and bladder carcinoma
CL Chaffer et al.
BMC CANCER (2006)
Proline oxidase, a proapoptotic gene, is induced by troglitazone -: Evidence for both peroxisome proliferator-activated receptor γ-dependent and -independent mechanisms
J Pandhare et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
Beyond peroxisome proliferator-activated receptor gamma signaling: the multi-facets of the antitumor effect of thiazolidinediones
J-R Weng et al.
ENDOCRINE-RELATED CANCER (2006)
Troglitazone sensitizes tumor cells to TRAIL-induced apoptosis via down-regulation of FLIP and Survivin
Kerstin Schultze et al.
APOPTOSIS (2006)
ET-18-O-CH3-induced apoptosis is causally linked to COX-2 upregulation in H-ras transformed human breast epithelial cells
HK Na et al.
FEBS LETTERS (2005)
Activation of PPARγ is not involved in butyrate-induced epithelial cell differentiation
S Ulrich et al.
EXPERIMENTAL CELL RESEARCH (2005)
Critical role of peroxisome proliferator-activated receptor γ on anoikis and invasion of squamous cell carcinoma
T Masuda et al.
CLINICAL CANCER RESEARCH (2005)
Inhibitors of the arachidonic acid pathway and peroxisome proliferator-activated receptor ligands have superadditive effects on lung cancer growth inhibition
I Avis et al.
CANCER RESEARCH (2005)
Peroxisome proliferator-activated receptor γ agonists promote TRAIL-induced apoptosis by reducing survivin levels via cyclin D3 repression and cell cycle arrest
ML Lu et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Thiazolidenediones mediate apoptosis in prostate cancer cells in part through inhibition of Bcl-xL/Bcl-2 functions independently of PPAR-γ
CW Shiau et al.
CANCER RESEARCH (2005)
15-Deoxy-Δ12,14-prostaglandin J2 induces apoptosis in human malignant B cells:: an effect associated with inhibition of NF-κB activity and down-regulation of antiapoptotic proteins
R Piva et al.
BLOOD (2005)
Death receptors in chemotherapy and cancer
KM Debatin et al.
ONCOGENE (2004)
Roles of CHOP/GADD153 in endoplasmic reticulum stress
S Oyadomari et al.
CELL DEATH AND DIFFERENTIATION (2004)
Expression of NAG-1, a transforming growth factor-β superfamily member, by troglitazone requires the early growth response gene EGR-1
SJ Baek et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
GW9662, a potent antagonist of PPARγ, inhibits growth of breast tumour cells and promotes the anticancer effects of the PPARγ agonist rosiglitazone, independently of PPARγ activation
JM Seargent et al.
BRITISH JOURNAL OF PHARMACOLOGY (2004)
Up-regulation of cyclooxygenase-2 expression is involved in R(+)-methanandamide-induced apoptotic death of human neuroglioma cells
B Hinz et al.
MOLECULAR PHARMACOLOGY (2004)
Ligands of peroxisome proliferator-activated receptor γ induce apoptosis in multiple myeloma
J Eucker et al.
ANTI-CANCER DRUGS (2004)
A retinoid X receptor (RXR)-selective retinoid reveals that RXR-alpha is potentially a therapeutic target in breast cancer cell lines, and that it potentiates antiproliferative and apoptotic responses to peroxisome proliferator-activated receptor ligands
DL Crowe et al.
BREAST CANCER RESEARCH (2004)
15-deoxy-Δ12,14-prostaglandin J2, a ligand for peroxisome proliferators-activated receptor-γ, induces apoptosis in human hepatoma cells
M Date et al.
LIVER INTERNATIONAL (2003)
Troglitazone, a peroxisome proliferator-activated receptor γ (PPARγ) ligand, selectively induces the early growth response-1 gene independently of PPARγ -: A novel mechanism for its anti-tumorigenic activity
SJ Baek et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
15-PGJ2, but not thiazolidinediones, inhibits cell growth, induces apoptosis, and causes downregulation of Stat3 in human oral SCCa cells
NG Nikitakis et al.
BRITISH JOURNAL OF CANCER (2002)
15-deoxy-Δ12,14-prostaglandin J2-induced apoptosis does not require PPARγ in breast cancer cells
CE Clay et al.
JOURNAL OF LIPID RESEARCH (2002)
Inhibitory effects of peroxisome proliferator-activated receptor γ on thyroid carcinoma cell growth
ML Martelli et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2002)
An inducible pathway for degradation of FLIP protein sensitizes tumor cells to TRAIL-induced apoptosis
Y Kim et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
Characteristics of the peroxisome proliferator activated receptor γ (PPARγ) ligand induced apoptosis in colon cancer cells
T Shimada et al.
GUT (2002)
PPARγ-mediated antineoplastic effect of NSAID sulindac on human oral squamous carcinoma cells
NG Nikitakis et al.
INTERNATIONAL JOURNAL OF CANCER (2002)
Activation of peroxisome proliferator-activated receptor-γ stimulates the growth arrest and DNA-damage inducible 153 gene in non-small cell lung carcinoma cells
T Satoh et al.
ONCOGENE (2002)
Peroxisome proliferator-activated receptor γ induces pancreatic cancer cell apoptosis
G Eibl et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2001)
Activation of the PPAR pathway induces apoptosis and COX-2 inhibition in HT-29 human colon cancer cells
WL Yang et al.
CARCINOGENESIS (2001)
Induction of apoptosis in prostate carcinoma cells by BH3 peptides which inhibit Bak/Bcl-2 interactions
NM Finnegan et al.
BRITISH JOURNAL OF CANCER (2001)
Ligands for peroxisome proliferator-activated receptor γ inhibit growth and induce apoptosis of human papillary thyroid carcinoma cells
K Ohta et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2001)
Pioglitazone inhibits growth of carcinoid cells and promotes TRAIL-induced apoptosis by induction of p21(waf1/cip1)
R Goke et al.
DIGESTION (2001)
Peroxisome proliferator activator receptor-γ agonists and 15-deoxy-Δ12,14-PGJ2 induce apoptosis in normal and malignant B-lineage cells
J Padilla et al.
JOURNAL OF IMMUNOLOGY (2000)
Expression of peroxisome proliferator-activated receptor (PPAR)γ in gastric cancer and inhibitory effects of PPARγ agonists
H Sato et al.
BRITISH JOURNAL OF CANCER (2000)
Inhibition of human lung cancer cell growth by the peroxisome proliferator-activated receptor-γ agonists through induction of apoptosis
Y Tsubouchi et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2000)
Regulation of TRAIL-induced apoptosis by transcription factors
R Göke et al.
CELLULAR IMMUNOLOGY (2000)
分享论文
